The Head of HALMED held a lecture on the Lareb conference on reporting suspected adverse reactions from patients
The Head of the Agency for Medicinal Products and Medical Devices (HALMED), Viola Macolić Šarinić, MD, PhD, held a lecture on the conference “Current perspectives and future possibilities”, dedicated to reporting suspected adverse reactions from patients, organised by Lareb in Leiden in the Netherlands from 23 to 24 April 2015.
The Head presented positive results, achieved by HALMED in the field of reporting adverse reactions, when it was first in the world to use the UMC’s on-line application for patient reporting. She also presented the exceptionally successful HALMED’s public educational campaign for promoting the importance of package leaflet reading and reporting adverse reactions and emphasised that this campaign had resulted in a three-fold increase in number of received reports from patients. The innovative co-operation started by HALMED with the theatre “Small Scene” with the aim to promote the importance of rational use of medicines and reporting of suspected adverse reactions among children, adolescents and adults was specially highlighted.
Further information is accessible under the link below.